SEC filing · 10-K

Incannex Healthcare Inc.: Annual report

Incannex Healthcare narrowed its net loss and increased its cash reserves to fund operations for at least twelve months.

Filed September 25, 2026 · period ended June 30, 2026

Mixed for the company

What the numbers say

Diluted EPS -$1.66 versus -$40.82; operating cash flow -$12.9M (a year earlier -$12.5M); free cash flow -$12.9M (a year earlier -$12.5M); cash rose by $52.7M to $67.7M; diluted share count up 915% (dilution).

Compared with the same period a year earlier, from the figures Incannex Healthcare Inc. reported to the SEC.

What happened

Cash and cash equivalents increased to $67.7 million as of June 30, 2026, driven by financing cash flows.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Incannex Healthcare Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.